Aurodox

Antibiotic compound

Aurodox
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Aurodox is a naturally occurring antibiotic compound that belongs to the class of antibiotics known as ansamycins. It is produced by the bacterium Streptomyces species, specifically Streptomyces goldiniensis. Aurodox is notable for its ability to inhibit bacterial protein synthesis, making it a potential therapeutic agent against certain bacterial infections.

Chemical Structure

Chemical structure of Aurodox

Aurodox is characterized by its unique chemical structure, which includes a spiroketal moiety. The IUPAC name for Aurodox is (3R)-3-hydroxy-4-methoxy-4-methyl-2-oxo-1-oxaspiro[2,5-dihydro-1H-pyrrole-3,2-oxetane]-5-carboxylic acid. This complex structure is responsible for its biological activity and its ability to interact with bacterial ribosomes.

Mechanism of Action

Aurodox functions by binding to the bacterial ribosome, specifically targeting the 50S subunit. This binding interferes with the translocation step of protein synthesis, effectively inhibiting the growth of bacteria. By preventing the proper assembly of proteins, Aurodox exerts its antibacterial effects, making it a valuable tool in the study of bacterial protein synthesis.

Production and Biosynthesis

Aurodox is produced by the actinobacterium Streptomyces goldiniensis. The biosynthesis of Aurodox involves a complex series of enzymatic reactions that assemble its intricate structure. The production of Aurodox by Streptomyces species is of significant interest in the field of biotechnology and pharmacology due to its potential applications in medicine.

Applications

While Aurodox has demonstrated antibacterial activity, its use in clinical settings is limited. However, it serves as an important research tool for understanding bacterial protein synthesis and the development of new antibiotics. The study of Aurodox and its derivatives continues to provide insights into the mechanisms of antibiotic resistance and the design of novel therapeutic agents.

Related Pages

• Antibiotic
• Streptomyces
• Ribosome
• Protein synthesis